Can Drugs Reduce the Risk of Long COVID? What Scientists Know So Far

For red and blue America, a glaring divide in COVID-19 death rates persists 2 years later. Post-vaccine, death rates in red states were 38% higher than in blue states.

Black patients with cancer fare worse with COVID-19, study shows

Russian Scientists Grapple with an Uncertain Future